Clinical Trial Update: An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial evaluating the efficacy and safety of Saredutant in patients with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Saredutant (saredutant)

Snippet

Sponsor: Sanofi | Conditions: Depressive Disorder | Phase 3 | Status: COMPLETED